[Genetic backgrounds of renal cell carcinoma].
Oya
Mototsugu
M
Department of Urology, Keio University School of Medicine.
D017766:Acid Anhydride Hydrolases / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000145:classification / Q000235:genetics* / Q000628:therapy; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics; D019175:DNA Methylation; D005649:Fumarate Hydratase / Q000235:genetics; D020868:Gene Silencing; D018095:Germ-Line Mutation; D006801:Humans; D007680:Kidney Neoplasms / Q000145:classification / Q000235:genetics* / Q000628:therapy; D019656:Loss of Heterozygosity; D009363:Neoplasm Proteins / Q000235:genetics; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000235:genetics; D000099170:Bis(5'-adenosyl)triphosphatase
D017766:Acid Anhydride Hydrolases; D005649:Fumarate Hydratase; D009363:Neoplasm Proteins; D019859:Proto-Oncogene Proteins c-met; D025521:Tumor Suppressor Proteins; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D000099170:Bis(5'-adenosyl)triphosphatase; C411762:RASSF1 protein, human; C497446:VHL protein, human